サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1376167

コエンザイムQ10（CoQ10）の市場規模、シェア、動向分析レポート：用途別、地域別、セグメント予測、2023年～2030年

Coenzyme Q10 Market Size, Share & Trends Analysis Report By Application (Dietary Supplements, Pharmaceuticals, Cosmetics, Others), By Region, And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 80 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.97円
コエンザイムQ10（CoQ10）の市場規模、シェア、動向分析レポート：用途別、地域別、セグメント予測、2023年～2030年
出版日: 2023年10月20日
発行: Grand View Research
ページ情報: 英文 80 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

コエンザイムQ10（CoQ10）市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のコエンザイムQ10（CoQ10）市場は、2023年から2030年にかけて10.2％のCAGRを記録し、2030年には13億3,000万米ドルに達する見込みです。

化粧品製剤での使用増加が業界成長の主な促進要因です。

CoQ10は抗酸化特性を示し、皮膚の修復をターゲットとしたエネルギー生成特性を示します。2015年には総量の半分以上を占める最大の消費者に浮上しました。人口の高齢化とそれに伴うアンチエイジング製品への需要が成長をさらに促進します。

アジア太平洋地域は、ほとんどの製造企業が中国に工場を開設し産業基盤が拡大していること、医薬品や栄養補助食品などの主要な最終用途産業が成長していることから、最も急成長する地域市場になる見通しです。ラテンアメリカはアジア太平洋に次ぐ成長を見せています。この成長は、栄養補助食品としての使用の増加や、多様な疾病の治療に起因しています。

栄養補助食品は、2015年の総市場量の60％以上を占める主要な用途分野でした。化粧品は、2016年から2024年にかけて10.4%という最も高い成長率が見込まれており、使用規制を遵守したスキンケアクリームやローションでの使用の増加が成長の原動力となっています。

コエンザイムQ10（CoQ10）市場レポートハイライト

  • CoQ10は、多様な生物において電子の移動と好気性細胞呼吸を担っています。CoQ10は、肝臓、腎臓、心臓などの高エネルギーを必要とする臓器に主に存在します。
  • CoQ10は栄養補助食品としてのみ販売されており、医療産業への応用の可能性は限られています。
  • 栄養補助食品セグメントは、2022年に60.9％の最大の売上シェアを占めました。同分野の成長は、抗酸化作用やエネルギー生成特性を含む有利な製品特性によって牽引される可能性が高いです。
  • 北米が市場を独占し、2022年には48.5%の最大収益シェアを占めました。アジア太平洋地域は予測期間中にCAGR 11.0％で成長すると予想されます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 コエンザイムQ10（CoQ10）の市場変数、動向、範囲

  • 市場系統の見通し
  • 普及と成長の見通しマッピング
  • バリューチェーン分析
  • 規制の枠組み
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
    • 業界の機会と課題
  • コエンザイムQ10（CoQ10）市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 サプライヤーのポートフォリオ分析

  • サプライヤー一覧
  • Kraljic Matrix
  • 調達のベストプラクティス
  • 交渉戦略

第5章 コエンザイムQ10（CoQ10）：用途の推定・動向分析

  • コエンザイムQ10（CoQ10）市場：重要なポイント
  • コエンザイムQ10（CoQ10）市場：動向と市場シェア分析、2022年および2030年
  • 栄養補助食品
  • 医薬品
  • 化粧品
  • その他

第6章 コエンザイムQ10（CoQ10）市場：地域の推定・動向分析

  • 地域の見通し
  • 地域別のコエンザイムQ10（CoQ10）市場：重要なポイント
  • 北米
  • 欧州
  • アジア太平洋地域
  • 世界のその他の地域

第7章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 市場参入企業の分類
    • KANEKA CORPORATION
    • MITSUBISHI GAS CHEMICAL COMPANY, INC.
    • Gnosis
    • Hwail Pharmaceutical CO., LTD.
    • KYOWA HAKKO U.S.A., INC.
    • DSM Nutritional Products AG
    • PharmaEssentia Corporation
    • ZMC-USA LLC
    • Nisshin Seifun Group Inc.
図表

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America coenzyme Q10 market, by application, 2018 - 2030 (USD Million, Tons)
  • Table 3 North America coenzyme Q10 market, by region, 2018 - 2030 (USD Million, Tons)
  • Table 4 U.S. coenzyme Q10 market, by application, 2018 - 2030 (USD Million, Tons)
  • Table 5 Canada coenzyme Q10 market, by application, 2018 - 2030 (USD Million, Tons)
  • Table 6 Mexico coenzyme Q10 market, by application, 2018 - 2030 (USD Million, Tons)
  • Table 7 Europe coenzyme Q10 market, by application, 2018 - 2030 (USD Million, Tons)
  • Table 8 Europe coenzyme Q10 market, by region, 2018 - 2030 (USD Million, Tons)
  • Table 9 Germany coenzyme Q10 market, by application, 2018 - 2030 (USD Million, Tons)
  • Table 10 UK coenzyme Q10 market, by application, 2018 - 2030 (USD Million, Tons)
  • Table 11 France coenzyme Q10 market, by application, 2018 - 2030 (USD Million, Tons)
  • Table 12 Italy coenzyme Q10 market, by application, 2018 - 2030 (USD Million, Tons)
  • Table 13 Belgium coenzyme Q10 market, by application, 2018 - 2030 (USD Million, Tons)
  • Table 14 Netherlands coenzyme Q10 market, by application, 2018 - 2030 (USD Million, Tons)
  • Table 15 Asia Pacific coenzyme Q10 market, by application, 2018 - 2030 (USD Million, Tons)
  • Table 16 Asia Pacific coenzyme Q10 market, by region, 2018 - 2030 (USD Million, Tons)
  • Table 17 China coenzyme Q10 market, by application, 2018 - 2030 (USD Million, Tons)
  • Table 18 Japan coenzyme Q10 market, by application, 2018 - 2030 (USD Million, Tons)
  • Table 19 India coenzyme Q10 market, by application, 2018 - 2030 (USD Million, Tons)
  • Table 20 Malaysia coenzyme Q10 market, by application, 2018 - 2030 (USD Million, Tons)
  • Table 21 South Korea coenzyme Q10 market, by application, 2018 - 2030 (USD Million, Tons)
  • Table 22 Rest of the World coenzyme Q10 market, by application, 2018 - 2030 (USD Million, Tons)
  • Table 23 Rest of the World coenzyme Q10 market, by region, 2018 - 2030 (USD Million, Tons)
  • Table 24 Brazil coenzyme Q10 market, by application, 2018 - 2030 (USD Million, Tons)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Coenzyme Q10: Market outlook
  • Fig. 9 Coenzyme Q10: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Coenzyme Q10 market driver impact
  • Fig. 15 Coenzyme Q10 market restraint impact
  • Fig. 16 Coenzyme Q10 market strategic initiatives analysis
  • Fig. 17 Coenzyme Q10 market: Application movement analysis
  • Fig. 18 Coenzyme Q10 market: Application outlook and key takeaways
  • Fig. 19 Dietary supplements market estimates and forecasts, 2018 - 2030
  • Fig. 20 Pharmaceuticals market estimates and forecasts, 2018 - 2030
  • Fig. 21 Cosmetics market estimates and forecasts, 2018 - 2030
  • Fig. 22 Others market estimates and forecasts, 2018 - 2030
  • Fig. 23 Global coenzyme Q10 market: Regional movement analysis
  • Fig. 24 Global coenzyme Q10 market: Regional outlook and key takeaways
  • Fig. 25 North America market estimates and forecasts, 2018 - 2030
  • Fig. 26 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 27 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 28 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 29 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 30 UK market estimates and forecasts, 2018 - 2030
  • Fig. 31 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 32 France market estimates and forecasts, 2018 - 2030
  • Fig. 33 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 34 Belgium market estimates and forecasts, 2018 - 2030
  • Fig. 35 Netherlands market estimates and forecasts, 2018 - 2030
  • Fig. 36 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 37 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 38 China market estimates and forecasts, 2018 - 2030
  • Fig. 39 India market estimates and forecasts, 2018 - 2030
  • Fig. 40 Malaysia market estimates and forecasts, 2018 - 2030
  • Fig. 41 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 42 Rest of the World market estimates and forecasts, 2018 - 2030
  • Fig. 43 Brazil market estimates and forecasts, 2018 - 2030
目次
Product Code: 978-1-68038-245-7

Coenzyme Q10 Market Growth & Trends:

The global coenzyme Q10 market is expected to reach USD 1.33 billion by 2030, according to a new report by Grand View Research, Inc.. registering a 10.2% CAGR from 2023 to 2030. Increasing use in cosmetic formulations is a key driving factor for industry growth.

CoQ10 exhibits antioxidant properties and energy generation characteristics targeting skin repair. It emerged as the largest consumer accounting for over half of the total volume in 2015. Aging population and the resulting demand for anti-aging products to further drive growth.

Asia Pacific is poised to be the fastest-growing regional market on account of expanding industrial base with most of the manufacturing companies opening plants in China and growing major end-use industries such as pharmaceutical and dietary supplements. Latin America would follow Asia Pacific in terms of growth. The growth can be attributed to increasing use as a dietary supplement and ailment of diverse diseases.

Dietary supplements were the dominant application segment accounting for over 60% of the total market volume in 2015. Cosmetics is expected to witness the highest growth rate of 10.4% from 2016 to 2024, growth is driven by increasing use in skincare creams and lotions in compliance with usage regulations.

Coenzyme Q10 Market Report Highlights:

  • CoQ10 is responsible for transferring electrons and aerobic cellular respiration in diverse organisms. It is majorly found in organs that require high energy such as the liver, kidney, and heart.
  • CoQ10 is sold only as a dietary supplement, restricting its potential applications in the medical industry.
  • The dietary supplements segment held the largest revenue share of 60.9% in 2022. The segment growth is likely to be driven by advantageous product characteristics that include antioxidant and energy generation properties.
  • North America dominated the market and accounted for the largest revenue share of 48.5% in 2022. Asia Pacific is expected to grow at the CAGR of 11.0% during the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Application
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Application outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Coenzyme Q10 Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
  • 3.5. Market Dynamics
    • 3.5.1. Market driver analysis
    • 3.5.2. Market restraint analysis
    • 3.5.3. Industry opportunities & challenges
  • 3.6. Coenzyme Q10 Market Analysis Tools
    • 3.6.1. Industry Analysis - Porter's
      • 3.6.1.1. Supplier power
      • 3.6.1.2. Buyer power
      • 3.6.1.3. Substitution threat
      • 3.6.1.4. Threat of new entrant
      • 3.6.1.5. Competitive rivalry
    • 3.6.2. PESTEL Analysis
      • 3.6.2.1. Political landscape
      • 3.6.2.2. Technological landscape
      • 3.6.2.3. Economic landscape
      • 3.6.2.4. Social landscape
      • 3.6.2.5. Environmental landscape
      • 3.6.2.6. Legal landscape

Chapter 4. Supplier Portfolio Analysis

  • 4.1. List of Suppliers
  • 4.2. Kraljic Matrix
  • 4.3. Sourcing Best Practices
  • 4.4. Negotiation Strategies

Chapter 5. Coenzyme Q10: Application Estimates & Trend Analysis

  • 5.1. Coenzyme Q10 Market: Key Takeaways
  • 5.2. Coenzyme Q10 Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Dietary Supplements
    • 5.3.1. Dietary supplements market estimates and forecasts, 2018 to 2030 (USD Million, Tons)
  • 5.4. Pharmaceuticals
    • 5.4.1. Pharmaceuticals market estimates and forecasts, 2018 to 2030 (USD Million, Tons)
  • 5.5. Cosmetics
    • 5.5.1. Cosmetics market estimates and forecasts, 2018 to 2030 (USD Million, Tons)
  • 5.6. Others
    • 5.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million, Tons)

Chapter 6. Coenzyme Q10 Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Coenzyme Q10 Market by Region: Key Takeaway
  • 6.3. North America
    • 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million; Volume, Tons, 2018 - 2030)
    • 6.3.2. U.S.
      • 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million; Volume, Tons, 2018 - 2030)
    • 6.3.3. Canada
      • 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million; Volume, Tons, 2018 - 2030)
    • 6.3.4. Mexico
      • 6.3.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million; Volume, Tons, 2018 - 2030)
  • 6.4. Europe
    • 6.4.1. Germany
      • 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million; Volume, Tons, 2018 - 2030)
    • 6.4.2. UK
      • 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million; Volume, Tons, 2018 - 2030)
    • 6.4.3. France
      • 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million; Volume, Tons, 2018 - 2030)
    • 6.4.4. Italy
      • 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million; Volume, Tons, 2018 - 2030)
    • 6.4.5. Belgium
      • 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million; Volume, Tons, 2018 - 2030)
    • 6.4.6. Netherlands
      • 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million; Volume, Tons, 2018 - 2030)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million; Volume, Tons, 2018 - 2030)
    • 6.5.2. China
      • 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million; Volume, Tons, 2018 - 2030)
    • 6.5.3. India
      • 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million; Volume, Tons, 2018 - 2030)
    • 6.5.4. Malaysia
      • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million; Volume, Tons, 2018 - 2030)
    • 6.5.5. South Korea
      • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million; Volume, Tons, 2018 - 2030)
  • 6.6. Rest of the World
    • 6.6.1. Brazil
      • 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million; Volume, Tons, 2018 - 2030)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. KANEKA CORPORATION
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. MITSUBISHI GAS CHEMICAL COMPANY, INC.
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Gnosis
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Hwail Pharmaceutical CO., LTD.
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. KYOWA HAKKO U.S.A., INC.
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. DSM Nutritional Products AG
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. PharmaEssentia Corporation
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. ZMC-USA LLC
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. Nisshin Seifun Group Inc.
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives